Journal
/
Immunology and Infection
/
Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Please note that all translations are automatically generated. Click here for the English version.

Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter

Deutsch

Automatically Generated

2,932 Views

•

07:44 min

•

August 12, 2021

DOI:

10.3791/62488-v

DOI:
10.3791/62488-v

•

07:44 min
August 12, 2021

•

1 Views
, , , , , , ,
1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology,University of Ottawa, 3Department of Biotechnology,University of Tehran

Summary

Automatically generated

Das skizzierte Protokoll beschreibt das Verfahren zur Herstellung des HiBiT-Rezeptor-bindenden Domänenproteinkomplexes und seine Anwendung für den schnellen und sensitiven Nachweis von SARS-CoV-2-Antikörpern.

Explore More Videos

SARS-CoV-2Receptor-binding DomainAntibody DetectionHiBiT-based BioreporterCOVID-19 ResearchHigh-throughput AssayCell CultureTransfectionPassive Lysis Buffer

Read Article

Cite this Article

Rezaei, R., Surendran, A., Singaravelu, R., Jamieson, T. R., Taklifi, P., Poutou, J., Azad, T., Ilkow, C. S. Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter. J. Vis. Exp. (174), e62488, doi:10.3791/62488 (2021).

Download .ris file

Copy

Share Video

.

Copy